AURA BIOSCIENCES INC's ticker is and the CUSIP is 05153U107. A total of 33 filers reported holding AURA BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $49 | -2.0% | 6,504 | +1.1% | 0.00% | – |
| Q1 2024 | $50 | -12.3% | 6,432 | -0.2% | 0.00% | – |
| Q4 2023 | $57 | -1.7% | 6,444 | -0.7% | 0.00% | – |
| Q3 2023 | $58 | -26.6% | 6,488 | +1.5% | 0.00% | – |
| Q2 2023 | $79 | -37.3% | 6,391 | -52.9% | 0.00% | – |
| Q1 2023 | $126 | -17.1% | 13,562 | -6.2% | 0.00% | – |
| Q4 2022 | $152 | -99.9% | 14,462 | -0.1% | 0.00% | – |
| Q3 2022 | $262,000 | +29.1% | 14,472 | +0.8% | 0.00% | – |
| Q2 2022 | $203,000 | +47.1% | 14,352 | +129.6% | 0.00% | – |
| Q1 2022 | $138,000 | +206.7% | 6,252 | +134.3% | 0.00% | – |
| Q4 2021 | $45,000 | – | 2,668 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $31,918,866 | 13.40% |
| Regency Capital Management Inc.\DE | 554,286 | $5,820,003 | 6.69% |
| Decheng Capital Management III (Cayman), LLC | 293,333 | $3,079,997 | 1.15% |
| Matrix Capital Management Company, LP | 5,362,870 | $56,310,135 | 1.08% |
| Monashee Investment Management LLC | 131,640 | $1,382,220 | 0.60% |
| Nantahala Capital Management | 798,751 | $8,386,886 | 0.54% |
| Eventide Asset Management | 2,251,368 | $23,639,364 | 0.47% |
| Rock Springs Capital Management LP | 1,019,757 | $10,707,449 | 0.26% |
| Artal Group S.A. | 410,000 | $4,305 | 0.24% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,132,739 | $22,393,760 | 0.05% |